Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B XNAS: LGND

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B Live Share Price Today, Share Analysis and Chart

Name: Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B: Is Infosys Ltd. worth buying?
Item: Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
Rating: 1.69172225
Author: Trendlyne DVM scores

Expensive Performer

Download real time

99.57 -3.54 (-3.43%)

47.03% Gain from 52W Low

163.0K XNAS Volume

XNAS 04 Apr, 2025 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Expensive Valuation

16.0 / 100

Technically Neutral

41.6 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

144

1Yr Price target upside is 44%

7 analysts

Ligand Pharmaceuticals, In... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B FAQ

How is Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B today?

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B today is trading in the red, and is down by -3.43% at 99.57.

How has Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B performed historically?

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B is currently trading down -3.43% on an intraday basis. In the past week the stock fell -7.48%. stock has been down -9.94% in the past quarter and rose 27.69% in the past year. You can view this in the overview section.